Three things to know:
1. The company requested approval for an updated package insert that includes 24-month follow-up data from subjects in the original clinical study.
2. i-Factor is a peptide enhanced bone graft that Cerapedics commercialized in 2016.
3. The biologic bone graft incorporates a small peptide as an attachment factor to stimulate the natural bone healing process.
More articles on biologics:
2 hospitals losing neurosurgery residency programs
Rothman, Carrum Health partner to expand healthcare benefits into tri-state area
Nexxt Spine to expand headquarters — 4 insights
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
